Abstract
5-FU: 5-fluoro-uracil ACEi: Angiotensin-converting enzyme inhibitor AF: Atrial fibrillation ARB: Angiotensin receptor blocker ARNI: Angiotension receptor neprilysin inhibitor AVB: Atrio-ventricular block CAD: Coronary artery disease CMP: Cardiomyopathy DOAC: Direct oral anticoagulant EMB: Endomyocardial biopsy ESR: Erythrocyte sedimentation rate FFR/iFR: Fractional flow reserve/instantaneous wave-free ratio GDMT: Goal directed medical therapy GLS: Global longitudinal strain IAS: Interatrial septum ICI: Immune checkpoint inhibitor IL-6: Interleukin 6 IMRT: Intensity-modulated radiation therapy LQTS: Long QT syndrome MCRA: Mineralocorticoid receptor antagonist MTX: methotrexate MUGA: Multigated acquisition PAD: Peripheral arterial disease PR: Pulmonic regurgitation PS: Pulmonic stenosis RFs: Risk factors ROS: Reactive oxygen species SCD: Sudden cardiac death TKI: Tyrosine kinase inhibitor TR: Tricuspid regurgitation TS: Tricuspid stenosis VEGFi: Vascular Endothelial Growth Factor inhibitors VT: Ventricular tachycardia VTE: Venous thromboembolism XRT: Radiation therapy.
Cite
CITATION STYLE
Gross, D. A., Hung, J. W., & Neilan, T. G. (2020). Cardio-Oncology and Tumors of the Heart. In MGH Cardiology Board Review: Second Edition (pp. 565–585). Springer International Publishing. https://doi.org/10.1007/978-3-030-45792-1_28
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
